{
    "title": "Glaxo SmithKline back in firing line",
    "url": "https://www.dailymail.co.uk/money/news/article-1703585/Glaxo-SmithKline-back-in-firing-line.html",
    "date": "2010-09-07",
    "keywords": [
        "drug",
        "mhra",
        "line",
        "september",
        "july",
        "avandia",
        "giant",
        "damage",
        "agency",
        "cost",
        "gsk",
        "year",
        "brummer",
        "mail",
        "gmt",
        "view",
        "glaxo",
        "charge",
        "effort",
        "issue",
        "diabetes",
        "pharma",
        "bottom",
        "bit",
        "damaging",
        "reputation",
        "depression",
        "seroxat",
        "paxil",
        "food",
        "administration",
        "efficacy",
        "light",
        "way",
        "safety",
        "work",
        "shape",
        "impact",
        "heart",
        "process",
        "record",
        "something",
        "hell",
        "case",
        "company",
        "size",
        "importance",
        "level",
        "meeting",
        "tomorrow",
        "medicines",
        "finding",
        "analysis",
        "shadow",
        "ema",
        "government",
        "quangoland",
        "event",
        "firestorm",
        "blockbuster",
        "class",
        "patent",
        "market",
        "decline",
        "atlantic",
        "impression",
        "website",
        "stuff",
        "gobbledygook",
        "use",
        "consumer",
        "openness"
    ],
    "category": [
        "money",
        "news"
    ]
}